Becker K, Heilmann C, Peters G: Coagulase-negative staphylococci. Clin Microbiol Rev 27: 870, 2014.
Maali Y, Martins-Simoes P, Valour F, et al.: Pathophysiological mechanisms of Staphylococcus non-aureus bone and joint infection: interspecies homogeneity and specific behavior of S. pseudintermedius. Front Microbiol 7: 1063, 2016.
Starlander G, Borjesson S, Gronlund-Andrsson U, et al.: Cluster of infections caused by methicillin-resistant Staphylococcus pseudintermedius in humans in a tertiary hospital. J Clin Microbiol 52: 3118, 2014.
Maaland MG, Papich MG, Turnidge J, et al.: Pharmacodynamics of doxycycline and tetracycline against Staphylococcus pseudintermedius: proposal of canine-specific breakpoints for doxycycline. J Clin Microbiol 51: 3547, 2013.
Wladyka B, Piejko M, Bzowska M, et al.: A peptide factor secreted by Staphylococcus pseudintermedius exhibits properties of both bacteriocins and virulence factors. Sci Rep 28: 14569, 2015.
Frank MG, Keniston A, Madinger N, et al.: Staphyloccocus intermedius group infections in humans: report of four cases and literature review. JMM Case Rep 2: 1, 2015.
Guardabassi L, Loeber ME, Jacobson A: Transmission of multiple antimicrobial-resistant Staphylococcus intermedius between dogs affected by deep pyoderma and their owners. Vet Microbiol 98: 23, 2004.
van Duijkeren E, Kamphuis M, van der Mije IC, et al.: Transmission of methicillin-resistant Staphyloccocus pseudintermedius between infected dogs and cats and contact pets, human the environment in households and veterinary clinics. Vet Microbiol 150: 338, 2011.
Rutland BE, Weese JS, Bolin C, et al.: Human-to-dog transmission of methicillin-resistant Staphlyococcus aureus. Emerg Infect Dis 15: 1328, 2009.
Pompilio A, De Nicola S, Crocetta V, et al.: New insights in Staphylococcus pseudintermedius pathogenicity: antibiotic-resistant biofilm formation by a human wound-associated strain. BMC Microbiol 15: 109, 2015.
Van Hoovels L, Vankeerberghen A, Boel A, et al.: First case of Staphylococcus pseudintermedius infection in a human. J Clin Microbiol 44: 4609, 2006.
Limbago BM: What’s in a name? the impact of accurate Staphylococcus pseudintermedius identification on appropriate antimicrobial susceptibility testing. J Clin Microbiol 54: 516, 2016.
Viau R, Hujer AM, Hujer KM, et al.: Are Staphylocccocus intermedius infections in humans cases of mistaken identity? a case series and literature review. Open Forum Infect Dis 2: ofv110, 2015.
Xu DH, Zhu Z, Fang Y: The effect of a common antibiotics doxycycline on non-healing chronic wound. Curr Pharm Biotechnol 18: 360, 2017.
Staphylococcus pseudintermedius is an emerging zoonotic pathogen that is very similar to human Staphylococcus pathogens, particularly multidrug-resistant Staphylococcus aureus. Recent reports have indicated that S pseudintermedius is easily transmitted between pets (mainly dogs) and owners because of these similarities. Although this pathogen has been associated with diabetic foot infections, it has not yet been described in the podiatric medical literature. In this case report, we present a diabetic foot infection in a 61-year-old man that was refractory to multiple rounds of antibiotic drug therapy. Deep wound cultures eventually grew S pseudintermedius, which was the first known case of this pathogen reported in our hospital system.